Vicore Pharma Holding AB

NASDAQ:VCRE

Medical - Pharmaceuticals

Healthcare
$9.90 -1.66%

-$0.24 today

Market cap
$279.65M
Beta
0.15

Volume 0.00M

Average 0.26M

VCRE Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

Vicore Pharma Holding ABNASDAQ: VCRE

Total Assets · Q2 FY2026 · quarter ended Jun 2026

Total assets of SEK 95.91M in Q2 FY2026

Q2 FY2026 total assets was SEK 95.91M.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
SEK 95.91M-91.1% QoQ
Last fiscal yearDec 2025
SEK 1.22B— YoY
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Assets history

SEK · from the balance sheet

Latest · FY2025
1.22B SEK
Year-over-year change
—

Total Assets vs competitors

How VCRE compares with its peers on the latest reported figures

  • Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
VCRE Competitors
Total Assets for VCRE and competitors
Company Period Latest balance YoY 3-year CAGR
LQDALiquidia CorporationJun 2026$521.92M USD+102.8%+36.4%
VCREVicore Pharma Holding ABJun 2026SEK 95.91M SEK——
AVLNAvalyn Pharma Inc. Common Stock—— ——
Peer median (excluding VCRE) —+102.8%+36.4%

Competitors are the stored peer set for VCRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Vicore Pharma Holding AB

NASDAQ:VCRE

Intrinsic Alpha fair value

Locked

Current Price

$9.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.